Navigation Links
Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations
Date:1/14/2014

ssness, coughing, mucus, and other symptoms.  (For more information, visit http://www.nhlbi.nih.gov/health/health-topics/topics/copd/.)  COPD affects over 24 million people in the US and over 64 million people worldwide.  Exacerbations are an acute worsening of the disease that can lead to substantial morbidity, including lost work days, clinic or emergency room visits, and hospitalizations, and may cause death.   Understanding these events and developing new treatments to reduce their frequency, severity, and duration, are important to patients and priorities for medical research.   The EXACT was designed to advance the science through precise, standardized assessment of exacerbations to facilitate basic and applied research on exacerbations, including onset, acuity, recovery, relapse, and the effects of preventive and acute treatment.  The EXACT is being used in multiple investigations, including pharmaceutical trials and natural history studies of COPD.  

"EXACT qualification marks a major milestone in the partnership between FDA and developers of patient-focused clinical outcome assessments (COAs) targeted for clinical trial use," said Laurie Burke, former Director of CDER's Study Endpoints and Labeling Development Staff that leads the COA qualification process at FDA.  "The EXACT development process enabled FDA to pave the way for more PRO measures to be qualified for drug development.  Moreover, COPD patients in clinical trials now have a clear voice in the measurement of treatment benefit and the development of new treatments based on their symptom experience."

About Evidera
Evidera, a wholly owned subsidiary of Symphony Technology Group, provides health economics, outcomes research, market access, data analytics and epidemiology services. We partner with life sciences organization
'/>"/>

SOURCE Evidera
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... HANOVER, N.J. , April 24, 2015  Novartis Pharmaceuticals ... for the second year in a row on the annual ... results of its 2015 Top 50 Companies for Diversity on ... York, NY . NPC also ranked second on the ... the Top 10 Companies for Employee Resource Groups list. ...
(Date:4/24/2015)... T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), a ... products and a licensed producer ("LP") to cultivate marijuana ... Canada ) ("MMPR"), is pleased to announce that ... the transaction announced on March 11, 2015 with Medna ... a total of 20,156,790 common shares of T-Bird (45% ...
(Date:4/23/2015)... , April 24, 2015  AbbVie (NYSE: ... Drug Administration (FDA) has accepted its New Drug Application ... interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir ... treatment of adults with chronic genotype 4 (GT4) hepatitis ... the first all-oral, interferon-free therapy being evaluated by the ...
Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
(Date:4/25/2015)... 25, 2015 For thirteen years, the Twin ... protection education event in the nation! This year, on May ... Group, US to take DI Day on the road by ... Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer at ... reflects on the change by stating, "The first Twin Cities ...
(Date:4/24/2015)... New York, NY (PRWEB) April 24, 2015 ... upscale sober living residence in Westchester County. Just 35 ... to help transition individuals back into everyday life while ... for Thursday, May 7, 2015, will allow therapists, doctors ... living areas and learn more about the opportunities offered ...
(Date:4/24/2015)... As the nation recognizes the Month of the ... young men and women, the “Alaska – Forget Me ... presents a special training session on Adverse Childhood Experiences ... understanding of the effect of childhood trauma and, in ... and military – who provide services and support to ...
(Date:4/24/2015)... April 24, 2015 Carvers' goal ... have a successful biking day in Breck. , ... five minutes walking distance from Breckenridge, this family-owned ... in both Breckenridge bike rentals ( http://www.breckenridgeskishop.com/en/rent-equipment ) ... offer extensive bike rentals in May 2015. With ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Lipitor ... forward in the federal multidistrict litigation underway in ... to court documents, the parties involved in the ... 16th detailing, among other things, preparation for the ... counsel for both plaintiffs and defendants have conducted ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Takes DI Day On The Road 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Carvers Breckenridge Bike Rentals Offers Demo Mountain, Tandem, Bike Path Cruiser & JR. Bikes in May 2015 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
... Silicone breast implants went through a long period of relative dormancy ... Now, two years after the U.S. Food and Drug Administration approved ... plastic surgeon Richard L. Zeff, MD comments on why he feels ... ...
... Corticon offers special pricing on patent-pending Dialogs, the premier platform ... ... Redwood City, CA (PRWEB) April 2, ... in model-driven Business Rules Management Systems (BRMS), today announced special ...
... Nurse Training, Inc., provider of nurse training seminars on DVD and online ... ... April 2, 2009 -- Medical Nurse Training, Inc., provider of nurse training ... its website., , ,Medical Nurse Training, Inc. provides DVD and online courses ...
... IT, a national provider of medical documentation services and software, announced ... innovative medical documentation company that serves more than 450 healthcare professionals ... ... (PRWEB) April 2, 2009 -- MD IT , a national ...
... pregnancy, such as morning sickness, fatigue and weight gain, but despite this, ... Gurgle, we offer a guide to women in their early stages of ... ... (PRWEB) April 2, 2009 -- Around half of all women will experience ...
... April 2 In the first,quarter of 2009 (December ... figure of EUR237.3m (Q1 2008: EUR239.1m) almost at the ... world economy. In,the core business, however, sales by the ... The operating result (adjusted EBITDA) ...
Cached Medicine News:Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 2Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 3Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 4Health News:Corticon Shows Business Transformation Potential of Dialogs, The First Intelligent Interactions Platform, at April 23 Webinar 2Health News:Corticon Shows Business Transformation Potential of Dialogs, The First Intelligent Interactions Platform, at April 23 Webinar 3Health News:Medical Nurse Training, Inc. Announces the Launch of Medicalnursetraining.com 2Health News:MD IT Expands in the Northwest with Acquisition of Seattle's Pro Scribe 2Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 2Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 3Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 4Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 5Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 2Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 3Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 4
Adjustable speed vortex with inter-changeable heads , 110 V...
Adjustable speed vortex with inter-changeable heads, 110 V...
... the Mo Bio Vortex Adapter in conjunction with ... procedures. Using the Mo Bio Vortex Adapter ... and Fast Prep machines which offer the same ... ml) centrifuge tubes at one time and will ...
... Vacuum Controller V-800 and water-cooled secondary condenser ... Compact Housing Model V-500 is a ... most vacuum applications. Applications Ideally ... evaporators Laboratory vacuum source for instruments ...
Medicine Products: